AtriCure, Inc. (ATRC): Price and Financial Metrics


AtriCure, Inc. (ATRC): $79.99

-0.69 (-0.86%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ATRC POWR Grades


  • Quality is the dimension where ATRC ranks best; there it ranks ahead of 60.73% of US stocks.
  • ATRC's strongest trending metric is Quality; it's been moving up over the last 31 weeks.
  • ATRC ranks lowest in Momentum; there it ranks in the 15th percentile.

ATRC Stock Summary

  • The ratio of debt to operating expenses for AtriCure Inc is higher than it is for about merely 24.47% of US stocks.
  • ATRC's price/sales ratio is 17.23; that's higher than the P/S ratio of 88.23% of US stocks.
  • In terms of volatility of its share price, ATRC is more volatile than 71.55% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to AtriCure Inc are PRO, XNCR, CLXT, SPNE, and PLAB.
  • Visit ATRC's SEC page to see the company's official filings. To visit the company's web site, go to www.atricure.com.

ATRC Valuation Summary

  • In comparison to the median Healthcare stock, ATRC's price/sales ratio is 35.43% higher, now standing at 17.2.
  • ATRC's price/sales ratio has moved up 1.1 over the prior 193 months.
  • Over the past 193 months, ATRC's EV/EBIT ratio has gone down 224.9.

Below are key valuation metrics over time for ATRC.

Stock Date P/S P/B P/E EV/EBIT
ATRC 2018-09-27 6.6 7.7 -60.5 -74.3
ATRC 2018-02-26 3.7 4.0 -19.2 -21.0
ATRC 2010-11-29 2.4 8.6 -21.9 -25.6
ATRC 2010-05-04 1.5 4.8 -5.0 -4.9
ATRC 2009-11-19 1.7 4.8 -5.1 -5.0
ATRC 2007-03-15 3.7 3.9 -9.9 -9.0

ATRC Growth Metrics

  • The 3 year net income to common stockholders growth rate now stands at 47.46%.
  • Its 5 year price growth rate is now at 132.83%.
  • Its 3 year net cashflow from operations growth rate is now at 16.61%.
Over the past 67 months, ATRC's revenue has gone up $89,274,000.

The table below shows ATRC's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-03-31 212.581 -13.098 -48.664
2020-12-31 206.531 -19.869 -48.155
2020-09-30 210.127 -27.352 -45.689
2020-06-30 211.984 -33.754 -50.102
2020-03-31 230.066 -18.46 -45.967
2019-12-31 230.807 -15.811 -35.194

ATRC Price Target

For more insight on analysts targets of ATRC, see our ATRC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $88.00 Average Broker Recommendation 1.19 (Strong Buy)

ATRC Stock Price Chart Interactive Chart >

Price chart for ATRC

ATRC Price/Volume Stats

Current price $79.99 52-week high $84.43
Prev. close $80.68 52-week low $34.04
Day low $79.41 Volume 229,406
Day high $81.27 Avg. volume 358,042
50-day MA $77.02 Dividend yield N/A
200-day MA $61.57 Market Cap 3.65B

AtriCure, Inc. (ATRC) Company Bio


Atricure provides atrial fibrillation solutions worldwide. The Company has three primary product lines for cardiac tissue ablation and a product line for left atrial appendage exclusion. The company was founded in 2000 and is based in West Chester, Ohio.


ATRC Latest News Stream


Event/Time News Detail
Loading, please wait...

ATRC Latest Social Stream


Loading social stream, please wait...

View Full ATRC Social Stream

Latest ATRC News From Around the Web

Below are the latest news stories about AtriCure Inc that investors may wish to consider to help them evaluate ATRC as an investment opportunity.

AtriCure: No Cure For High Prices

Anna Frank/E+ via Getty Images Almost a year ago, I called AtriCure (ATRC) a steady growth play, yet one with lackluster margins. I observed that the company was a steady medtech growth name, yet the problem is that the company has been losing money since the IPO 15 years ago,...

The Value Investor on Seeking Alpha | July 15, 2021

Cryoablation Devices Market Overview, Size, Share Opportunities and Challenges By Major Players Medtronic, CooperSurgical, AtriCure, Galil Medical, BVM Medical, etc.

Up Market Research (UMR) announces the release of a new report, Cryoablation Devices Market Research Report 2021. The statistics and insights provide an in-depth look into the market and opportunities. The report provides a comprehensive analysis of key market shares, size, trends, and forecasts for the global Cryoablation Devices market. It also covers data on []

Tramways Monthly | July 12, 2021

The Daily Biotech Pulse: Lilly, Morphic''s Positive Data At ECCO, Humanigen''s COVID Treatment Gets Expedited Review In UK, TransCode IPO

Here''s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc. (NASDAQ: ARPO ) ( moved on positive analyst action) Ambrx Biopharma Inc. (NYSE: AMAM ) AtriCure, Inc. (NASDAQ: ATRC ) Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN ) BioLife Solutions, Inc. (NASDAQ: BLFS ) Edwards Lifesciences Corporation (NYSE: EW ) Novo Nordisk A/S (NYSE: NVO ) Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX ) West Pharmaceutical Services, Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 8) 89bio, Inc. (NASDAQ: ETNB ) AbCellera Biologics Inc. (NASDAQ: ABCL ) Achilles Therapeutics plc (NASDAQ: ACHL ) Adicet Bio, Inc. (NASDAQ: ACET ) ADMA Biologics, Inc. (NASD...

Benzinga | July 9, 2021

AtriCure to Announce Second Quarter 2021 Financial Results

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release second quarter 2021 financial results on Wednesday, August 4, 2021. AtriCure will host a conference call at 4:30 p.m. Eastern Time on Wednesday, August 4, 2021 to discuss its second quarter 2021 financial results. The call may be accessed through an operator by calling (844) 884-9951 for dom

Business Wire | July 7, 2021

Radiofrequency Ablation Device Market - Boston Scientific, St Jude Medical, Medtronic, Covidien and Stryker, Imricor Medical Systems, AtriCure, BIOTRONIK, MicroPort Scientific and Spacelabs Healthcare.

Coherent Market Insights has announced the addition of the Global Radiofrequency Ablation Device Market Size, Status and Forecast 2027, The report classifies the market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well

OpenPR | June 28, 2021

Read More 'ATRC' Stories Here

ATRC Price Returns

1-mo -0.24%
3-mo 14.52%
6-mo 39.11%
1-year 75.11%
3-year 187.73%
5-year 443.41%
YTD 43.69%
2020 71.24%
2019 6.24%
2018 67.76%
2017 -6.80%
2016 -12.79%

Continue Researching ATRC

Here are a few links from around the web to help you further your research on AtriCure Inc's stock as an investment opportunity:

AtriCure Inc (ATRC) Stock Price | Nasdaq
AtriCure Inc (ATRC) Stock Quote, History and News - Yahoo Finance
AtriCure Inc (ATRC) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.1059 seconds.